Cardiol Therapeutics | WebDisclosure

Basculer en Français

10940	Companies
238980	Keywords
167818	Articles
128470	Press releases

Home
Companies
Cardiol Therapeutics

PRESS RELEASE

published on 02/27/2024 at 14:16, 2 years 6 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates BUY recommendation on Cardiol Therapeutics Inc. FDA grants Orphan Drug Designation for CardiolRx in pericarditis treatment. Positive phase II study results expected in Q2 2024

FDA Cardiol Therapeutics Inc First Berlin Equity Research Orphan Drug Designation Pericarditis
BRIEF

published on 02/27/2024 at 14:16, 2 years 6 months ago

Cardiol Therapeutics Receives FDA Orphan Drug Designation for CardiolRx

FDA Investment Orphan Drug Designation Cardiol Therapeutics Pericarditis
BRIEF

published on 02/27/2024 at 14:16, 2 years 6 months ago

Cardiol Therapeutics obtient la désignation de médicament orphelin par la FDA pour CardiolRx

Investissement FDA Orphan Drug Designation Cardiol Therapeutics Pericardite
PRESS RELEASE

published on 01/19/2024 at 12:41, 2 years 7 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research has published an update on Cardiol Therapeutics Inc., reaffirming its BUY recommendation and maintaining the price target of USD 3.60. The report highlights the progress in patient recruitment for CardiolRx's two lead indications, acute myocarditis (AM) and recurrent pericarditis (RP), with expectations of significant near-term catalysts for the stock. Analyst Christian Orquera remains optimistic about the company's investment potential. For the full analysis, visit the link provided.

Cardiol Therapeutics Inc First Berlin Equity Research Buy Recommendation Patient Recruitment Investment Potential
PRESS RELEASE

published on 08/30/2023 at 15:06, 3 years ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE

published on 05/24/2023 at 13:01, 3 years 3 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE

published on 04/11/2023 at 15:26, 3 years 4 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy

Accesswire

Published on 09/05/2026 at 04:05, 2 days 13 hours ago

Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 2 days 18 hours ago

FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 2 days 18 hours ago

Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 2 days 19 hours ago

Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 3 days 3 hours ago

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)

View all ACCESSWIRE

EQS Group

Published on 09/07/2026 at 17:11, 37 minutes ago

EQS-Adhoc: fox e-mobility AG: Unqualified Audit Opinion for 2024 Financial Statements / Preliminary Figures for 2025 and First Half 2026
Published on 09/07/2026 at 16:10, 1 hour 38 minutes ago

Redcare Pharmacy welcomes further progress on PoPP: New preliminary specification lays the groundwork for Health ID in remote care.
Published on 09/07/2026 at 16:02, 1 hour 46 minutes ago

Original-Research: LAIQON AG (von First Berlin Equity Research GmbH): Buy
Published on 09/07/2026 at 16:01, 1 hour 47 minutes ago

Holding(s) in Company
Published on 09/07/2026 at 16:00, 1 hour 48 minutes ago

HUAWEI Mate XT 2 | ULTIMATE DESIGN Debuts as the First Smartphone to Feature LogicFolding Tau (τ) Chip and Reach Mass Commercialization

Les Echos

Published on 09/07/2026 at 17:40, 7 minutes ago

Reporting on share buyback transactions carried out between 2 and 3 September, 2026
Published on 09/07/2026 at 17:40, 7 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 2 et 3 septembre 2026
Published on 09/07/2026 at 17:35, 13 minutes ago

Disclosure of the number of shares and the total number of voting rights as of August 31, 2026
Published on 09/07/2026 at 17:35, 13 minutes ago

Déclaration du nombre d'actions composant le capital et du nombre total de droits de vote au 31 août 2026
Published on 09/07/2026 at 15:03, 2 hours 44 minutes ago

voting rights

View all LES ECHOS COMFI WIRE